China's Phase One AIDS Vaccine Trial Nears End
Posted on: Sunday, 18 September 2005, 09:00 CDT
China's phase one AIDS vaccine trial nears end
NANNING, Sept. 17 (Xinhua) -- Fifteen volunteers were injected with Chinese home made AIDS vaccine Sunday in Nanning, capital of south China's Guangxi Zhuang Autonomous Region, a signal China's phase one AIDS vaccine trial test has entered the final phase, said a Chinese medical expert.
Chen Jie, deputy director of Guangxi autonomous regional disease control center, said clinical data of all the volunteers will serve a scientific basis to show whether the second phase trial project of AIDS vaccine will start.
All the 49 volunteers for the phase-one trial test, divided into eight groups, were all in good physical condition and no one ever quit.
The State Food and Drug Administration (SFDA) approved the first clinical phase of the new AIDS vaccine on Nov. 25, 2004. There have been 35 AIDS vaccine trial tests on humans around the world, most of which are still at the early phase. With its first AIDS case reported in 1985, China now has an estimated 840,000 HIV carriers and AIDS patients, according to sources with Chinese medical authorities.
Source: Xinhua News Agency - CEIS
Related Articles
- Phase 1 Clinical Trials For HIV/AIDS Vaccine Underway
- Sinovac Announces Pandemic Influenza Vaccine Phase I Clinical Trial Preliminary Results
- Sinovac Completes Immunization Schedule in the Phase I Clinical Trial of Its Proprietary Avian Influenza Vaccine (H5N1)
- IAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test Targeted Genetics' HIV Vaccine Candidate
- South Africa to host phase II AIDS vaccine trials
- S.Africa to host phase 2 AIDS vaccine trials
- Vical DNA Vaccine Technology Enters Phase 2 Clinical Trial for HIV
- Phase One Trial of China's AIDS Vaccine Near Completion
- MedImmune Begins Dosing in Phase 1 Clinical Trial for Nasally Delivered Vaccine Designed to Help Prevent Common Childhood Respiratory Viral Diseases
User Comments (0)


RSS Feeds